Thalidomide has been found to exhibit weak nitric oxide synthase (NOS)-inhibitory activity. Structural development studies of thalidomide showed that some N-2,6-dimethylphenylhomophthalimide analogs possess NOS-inhibiting activity.
沙利度胺被发现具有弱的硝氧化酶(NOS)抑制活性。
沙利度胺的结构开发研究表明,一些N-2,6-二甲基苯基同苯二甲
酰亚胺类似物具有抑制NOS的活性。